SNOA

Sonoma Pharmaceuticals, Inc. SNOA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SNOA SXTC BFRI SONN PHIO EDSA XBIO NAOV
6M 76.42 % -40.64 % 14.29 % 241.86 % 26.55 % 10.67 % 175.22 % -90.66 %
YTD 50.75 % -62.10 % -11.93 % 175.63 % 15.89 % 30.37 % 56.30 % -90.73 %
1Y 31.17 % -67.08 % 17.22 % -4.75 % -18.14 % -42.09 % 70.62 % -90.73 %
3Y -89.58 % -98.93 % -95.83 % -98.03 % -96.42 % -65.13 % 17.22 % -99.35 %
5Y -97.64 % -99.97 % -98.91 % -99.97 % -99.07 % -95.22 % -30.52 % -99.59 %
10Y -99.62 % -100.00 % -98.91 % -100.00 % -100.00 % -99.88 % -98.97 % -99.93 %
From the beginning -99.99 % -100.00 % -98.91 % -100.00 % -99.30 % -99.58 % -98.97 % -99.92 %

Dividend